Global Medical Affairs Summit

The activities of Medical Affairs in pharmaceutical companies are considered as a key component of a successful product launch. During the last few years, the scope of Medical Affairs has changed and became even more relevant. As a Medical Affairs expert you need to keep pace with this changing role and this exclusive pharma event gives you the chance to be informed about all necessary updates in Medical Affairs sphere. Join our Global Medical Affairs conference, meet professionals from the best pharma companies and learn what the new trends in Medical Affairs are, how to maximise the value of RWE, the usage of data in Medical Affairs, the importance of patient centricity and patient outcomes, the present and future of Medical Information. At this unique business conference you will also listen to some case studies about cross-collaboration, strategic partnerships, Medical Affairs digitalisation and many other topics. Do not miss the opportunity to exchange knowledge and experience with the best Medical Affairs professionals at the Global Medical Affairs event during 12 - 13 June 2019 in Berlin! Be aware that tickets to this business meeting are limited, so do not hesitate and register today!

Join us and register today

Stay on top of the latest trends

Register now

Key speakers

Klaus VIEL

Klaus VIEL

Head Global Medical Affairs Operations

Daniel KALANOVIC

Daniel KALANOVIC

Vice President, Global Medical Team Lead, Immuno-Oncology, Lung Cancer, Renal Cancer

Imane WILD

Imane WILD

Senior VP Global Head of Medical Affairs

Zsolt BOSNYAK

Zsolt BOSNYAK

Senior Director, Global Medical Head

Georgios TRAMOUNTANIS

Georgios TRAMOUNTANIS

Director, Global Medical Information & Review

Pierre-Henri BELIN

Pierre-Henri BELIN

Global Commercial Integration Head

Key topics

Data Management – How to use data to support outsourcing in medical affairs?
Maximising the current & future value of Real Word Evidence
Investigator initiated trials (IITs) - exploring the field for new indications
Building a patient-focused strategy to launch a product
Transforming the product benefits into relevant insights for the patients
Cross-collaboration between medical affairs and other departments
How to improve the patient outcomes?
Opportunities for medical affairs in emerging markets
Compliance issues related to the MSL-KOL relationship

Who Should Attend

Members of board, C-level, Senior/Global Vice Presidents, Directors, and Heads of departments from pharmaceutical industry involved in: